Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen

Gene Therapy
K F HsuT-C Wu

Abstract

Naked DNA vaccines represent an attractive approach for generating antigen-specific immunity because of their stability and simplicity of delivery. There are particular concerns with DNA vaccines however, such as potential integration into the host genome, cell transformation, and limited potency. The usage of DNA-based alphaviral RNA replicons (suicidal DNA vectors) may alleviate the concerns of integration or transformation since suicidal DNA vectors eventually cause lysis of transfected cells. To improve further the potency of suicidal DNA vaccines, we evaluated the effect of linking Mycobacterium tuberculosis heat shock protein 70 (Hsp70) to human papillomavirus type 16 (HPV-16) E7 as a model antigen on antigen-specific immunity generated by a DNA-based Semliki Forest virus (SFV) RNA vector, pSCA1. Our results indicated that this suicidal DNA vaccine containing E7/Hsp70 fusion genes generated significantly higher E7-specific T cell-mediated immune responses than vaccines containing the wild-type E7 gene in vaccinated mice. More importantly, this fusion converted a less effective vaccine into one with significant potency against established E7-expressing metastatic tumors. The antitumor effect was predominantly CD8-dependent...Continue Reading

References

May 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·D V HeckK Münger
Oct 1, 1994·Current Opinion in Immunology·T C Wu
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·T C WuD M Pardoll
Jan 1, 1997·Annual Review of Immunology·J J DonnellyM A Liu
Jun 1, 1997·Vaccine·H L Robinson
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·K SuzueR A Young
May 19, 1998·Nature Medicine·D M Pardoll
Jun 13, 1998·Nature Biotechnology·P BerglundP Liljeström
Jul 11, 1998·The Journal of Biological Chemistry·D P DiCiommo, R Bremner
Aug 6, 1998·Journal of Biomedical Science·C H Chen, T C Wu
Jul 8, 1999·Nature Medicine·H YingN P Restifo
Nov 24, 1999·Immunological Reviews·R F Wang, S A Rosenberg

❮ Previous
Next ❯

Citations

Oct 13, 2006·Springer Seminars in Immunopathology·David A Hokey, David B Weiner
Oct 16, 2004·Current Oncology Reports·Dorothy J WileyKristina Morgan
Mar 13, 2010·Cell Stress & Chaperones·Nafiseh PakravanZuhair Mohammad Hassan
Jun 20, 2003·Veterinary Immunology and Immunopathology·Vinciane Dufour, Claire De Boisséson
Sep 27, 2003·Methods : a Companion to Methods in Enzymology·Hanns Hauser, Si-Yi Chen
Mar 16, 2011·Anti-cancer Drugs·Amanda PsyrriSofia Karageorgopoulou
Apr 18, 2009·Current Opinion in Oncology·Amanda PsyrriJan Baptist Vermorken
Mar 5, 2010·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Jun-Han SuT-C Wu
Jul 21, 2005·Cancer Immunology, Immunotherapy : CII·Min Yu, Olivera J Finn
Apr 9, 2008·Journal of Biomedical Science·Annie A WuSara I Pai
Aug 9, 2007·Pharmaceutical Research·Megan E PearceAliasger K Salem
Oct 2, 2014·Expert Review of Vaccines·Karl Ljungberg, Peter Liljeström
Aug 9, 2003·Expert Review of Vaccines·Kenneth Lundstrom
Jun 18, 2014·Viruses·Kenneth Lundstrom
Nov 17, 2015·Expert Review of Anticancer Therapy·Gulden MenderesAlessandro D Santin
Mar 21, 2008·Expert Opinion on Biological Therapy·Chien-Fu HungT-C Wu
Jul 30, 2005·Expert Opinion on Biological Therapy·Delia J NelsonRobbert van der Most
Oct 10, 2009·Journal of Drug Targeting·Joost H van den BergWim E Hennink
Aug 10, 2010·Virus Research·Jose I QuetglasCristian Smerdou
Jul 25, 2009·Cancer Letters·Ha Linh VuJohnny Kao
Feb 24, 2016·Expert Review of Vaccines·Andrew YangChien-Fu Hung
May 20, 2015·Human Vaccines & Immunotherapeutics·Si-Hyeong LeeJeong-Im Sin
Mar 17, 2010·The Journal of Gene Medicine·Nafiseh PakravanZuhair Mohammad Hassan
Mar 29, 2014·Journal of Experimental & Clinical Cancer Research : CR·Patrizia ViciAldo Venuti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.